Robert E. Gagnon
CIK 1504983 · Chief Financial Officer · last filed 2026-09-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
HBIO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
117 KENDRICK STREET, SUITE 500
NEEDHAM, MA 02494
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BBLG | Director | — | $0.36 | — | $0 | 1 | 2026-09-30 |
| IRD | Chief Financial Officer | 556,375 | $3.45 | $1.92M | -$150.2K | 2 | 2026-09-08 |
| HBIO | Chief Financial Officer | 27,556 | $8.41 | $231.9K | -$2.37M | 26 | 2026-06-11 |
| Opus Genetics, Inc. (OCUP) Delisted | Chief Financial Officer | 592,158 | $1.17 | $692.8K | -$40.7K | 3 | 2026-04-27 |
| VSTM | Director | 41,678 | $9.92 | $413.4K | -$338.4K | 33 | 2025-12-18 |
| BBLGW | Director | — | $7.70 | — | $0 | 3 | 2025-06-06 |
| CLEAN HARBORS INC (CLHB) Delisted | EVP CFO and Treasurer | 5,000 | — | — | $0 | 1 | 2012-09-13 |
| BIIB | Vice President, Finance | 3,999 | $251.47 | $1.01M | -$1.37M | 23 | 2012-03-01 |
Recent Filings · Page 7 of 11
101 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-07-11 | HBIO | Mixed | −25,028 | -$278.4K | EDGAR |
| 2018-05-29 | HBIO | Grant (A) | +80,000 | $0 | EDGAR |
| 2018-05-08 | HBIO | Tax (F) | −26,081 | -$130.4K | EDGAR |
| 2018-03-12 | HBIO | Sell (S) | −97,087 | -$448.5K | EDGAR |
| 2018-01-04 | HBIO | Tax (F) | −20,048 | -$66.2K | EDGAR |
| 2017-05-30 | HBIO | Mixed | +218,392 | $2.3K | EDGAR |
| 2017-01-04 | HBIO | Tax (F) | −10,868 | -$33.1K | EDGAR |
| 2016-11-03 | HBIO | Buy (P) | +25,000 | $58.5K | EDGAR |
| 2016-05-10 | HBIO | Grant (A) | +177,304 | $0 | EDGAR |
| 2016-01-05 | HBIO | Tax (F) | −2,476 | -$8.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.